{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047376","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2024-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.411399+00:00","generated_at":"2026-05-29T19:28:45.936147+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Protagenic Therapeutics receives Nasdaq delisting notice; stock suspension set for Nov 29","bullets":["Failed to meet Nasdaq's minimum $2.5M stockholders' equity requirement by Nov 18, 2024, after extension.","Nasdaq delist determination letter received Nov 19; trading of PTIX stock to suspend on Nov 29 unless appeal.","Company may request Nasdaq hearing to stay delisting, but no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047376","json":"https://secwatch.observer/filing/0001493152-24-047376.json","markdown":"https://secwatch.observer/filing/0001493152-24-047376.md","text":"https://secwatch.observer/filing/0001493152-24-047376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224047376/0001493152-24-047376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224047376/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T19:28:45.936147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}